ECM
ISEE

ExodusPoint Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

ExodusPoint Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200,000
Closed -$1.39M – 2742
2020
Q4 		$1.39M Buy
+200,000
New +$1.28M 0.01% 697

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

ExodusPoint Capital Management's ISEE Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 62,666 shares — an estimated $1.52M sold.

ExodusPoint Capital Management first reported a position in ISEE in Q4 2019 and held it in 8 quarters. The position peaked at $2.3M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • ExodusPoint Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 62,666 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.52M.
  • ExodusPoint Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • ExodusPoint Capital Management's IVERIC bio, Inc. Common Stock position peaked at $2.3M in Q3 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.